{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T00:15:27Z","timestamp":1793146527992,"version":"4.5.0"},"reference-count":71,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82102770"],"award-info":[{"award-number":["82102770"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018556","name":"Science and Technology Program of Suzhou","doi-asserted-by":"publisher","award":["SZM2023019"],"award-info":[{"award-number":["SZM2023019"]}],"id":[{"id":"10.13039\/501100018556","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Biological Macromolecules"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.ijbiomac.2026.152623","type":"journal-article","created":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T23:19:36Z","timestamp":1779232776000},"page":"152623","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["The USP7\u2013VIM axis mediates lipid metabolic remodelling and compromises CD8+ T-cell mitochondrial fitness in glioblastoma"],"prefix":"10.1016","volume":"368","author":[{"given":"Liyan","family":"Tang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinming","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yulun","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuetao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11\u221212","key":"10.1016\/j.ijbiomac.2026.152623_bb0005","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1101\/gad.324301.119","article-title":"Glioblastoma stem cells: lessons from the tumor hierarchy in a lethal cancer","volume":"33","author":"Gimple","year":"2019","journal-title":"Genes Dev."},{"issue":"2","key":"10.1016\/j.ijbiomac.2026.152623_bb0010","doi-asserted-by":"crossref","DOI":"10.3390\/v15020547","article-title":"Recent developments in glioblastoma therapy: oncolytic viruses and emerging future strategies","volume":"15","author":"Hamad","year":"2023","journal-title":"Viruses"},{"issue":"3","key":"10.1016\/j.ijbiomac.2026.152623_bb0015","doi-asserted-by":"crossref","first-page":"186","DOI":"10.2174\/1389200221666200408083950","article-title":"Therapeutics and research related to glioblastoma: advancements and future targets","volume":"21","author":"Chavda","year":"2020","journal-title":"Curr. Drug Metab."},{"issue":"5","key":"10.1016\/j.ijbiomac.2026.152623_bb0020","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.3002640","article-title":"Understanding glioblastoma at the single-cell level: recent advances and future challenges","volume":"22","author":"Yabo","year":"2024","journal-title":"PLoS Biol."},{"key":"10.1016\/j.ijbiomac.2026.152623_bb0025","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1255611","article-title":"Immunotherapy: a promising approach for glioma treatment","volume":"14","author":"Yasinjan","year":"2023","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.152623_bb0030","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1186\/s40478-019-0803-6","article-title":"Immune landscapes associated with different glioblastoma molecular subtypes","volume":"7","author":"Martinez-Lage","year":"2019","journal-title":"Acta Neuropathol. Commun."},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.152623_bb0035","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s10555-021-09997-9","article-title":"Glioma: molecular signature and crossroads with tumor microenvironment","volume":"41","author":"Barthel","year":"2022","journal-title":"Cancer Metastasis Rev."},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.152623_bb0040","article-title":"Tumor microenvironment in glioblastoma: current and emerging concepts","volume":"5","author":"Sharma","year":"2023","journal-title":"Neurooncol. Adv."},{"issue":"6","key":"10.1016\/j.ijbiomac.2026.152623_bb0045","doi-asserted-by":"crossref","first-page":"8509","DOI":"10.1002\/jcp.27782","article-title":"CD8(+) cytotoxic T lymphocytes in cancer immunotherapy: a review","volume":"234","author":"Farhood","year":"2019","journal-title":"J. Cell. Physiol."},{"issue":"9","key":"10.1016\/j.ijbiomac.2026.152623_bb0050","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/j.tcb.2020.06.003","article-title":"The roles of CD8(+) t cell subsets in antitumor immunity","volume":"30","author":"St Paul","year":"2020","journal-title":"Trends Cell Biol."},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.152623_bb0055","doi-asserted-by":"crossref","first-page":"6938","DOI":"10.1038\/s41467-021-26940-2","article-title":"Neoadjuvant PD-1 blockade induces T cell and cDC1 activation but fails to overcome the immunosuppressive tumor associated macrophages in recurrent glioblastoma","volume":"12","author":"Lee","year":"2021","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.152623_bb0060","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.immuni.2022.12.008","article-title":"Microenvironment-driven metabolic adaptations guiding CD8(+) T cell anti-tumor immunity","volume":"56","author":"Park","year":"2023","journal-title":"Immunity"},{"issue":"5","key":"10.1016\/j.ijbiomac.2026.152623_bb0065","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1038\/labinvest.2017.19","article-title":"Immune microenvironment of gliomas","volume":"97","author":"Gieryng","year":"2017","journal-title":"Lab. Investig."},{"key":"10.1016\/j.ijbiomac.2026.152623_bb0070","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1212476","article-title":"Cancer immunotherapies: advances and bottlenecks","volume":"14","author":"Rui","year":"2023","journal-title":"Front. Immunol."},{"issue":"23","key":"10.1016\/j.ijbiomac.2026.152623_bb0075","doi-asserted-by":"crossref","DOI":"10.3390\/cells11233924","article-title":"Unbalanced glutamine partitioning between CD8T cells and Cancer cells accompanied by immune cell dysfunction in hepatocellular carcinoma","volume":"11","author":"Chen","year":"2022","journal-title":"Cells"},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.152623_bb0080","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/s41568-019-0226-5","article-title":"Altered cellular metabolism in gliomas - an emerging landscape of actionable co-dependency targets","volume":"20","author":"Bi","year":"2020","journal-title":"Nat. Rev. Cancer"},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.152623_bb0085","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.cmet.2019.11.010","article-title":"Greasing the wheels of the Cancer machine: the role of lipid metabolism in Cancer","volume":"31","author":"Snaebjornsson","year":"2020","journal-title":"Cell Metab."},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.152623_bb0090","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/s41420-024-01841-7","article-title":"Hsa_circ_0021205 enhances lipolysis via regulating miR-195-5p\/HSL axis and drives malignant progression of glioblastoma","volume":"10","author":"Li","year":"2024","journal-title":"Cell Death Discov."},{"issue":"6","key":"10.1016\/j.ijbiomac.2026.152623_bb0095","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1242\/dmm.011338","article-title":"Hooked on fat: the role of lipid synthesis in cancer metabolism and tumour development","volume":"6","author":"Baenke","year":"2013","journal-title":"Dis. Model. Mech."},{"issue":"40","key":"10.1016\/j.ijbiomac.2026.152623_bb0100","doi-asserted-by":"crossref","first-page":"4512","DOI":"10.1038\/s41388-022-02445-0","article-title":"Dual role of pseudogene TMEM198B in promoting lipid metabolism and immune escape of glioma cells","volume":"41","author":"Zhan","year":"2022","journal-title":"Oncogene"},{"issue":"6","key":"10.1016\/j.ijbiomac.2026.152623_bb0105","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/j.ccell.2023.05.001","article-title":"CDKN2A deletion remodels lipid metabolism to prime glioblastoma for ferroptosis","volume":"41","author":"Minami","year":"2023","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ijbiomac.2026.152623_bb0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.plipres.2023.101250","article-title":"Triacylglycerol uptake and handling by macrophages: from fatty acids to lipoproteins","volume":"92","author":"Deng","year":"2023","journal-title":"Prog. Lipid Res."},{"issue":"9","key":"10.1016\/j.ijbiomac.2026.152623_bb0115","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1515\/hsz-2012-0192","article-title":"Adipose triglyceride lipase in immune response, inflammation, and atherosclerosis","volume":"393","author":"Radovic","year":"2012","journal-title":"Biol. Chem."},{"issue":"7","key":"10.1016\/j.ijbiomac.2026.152623_bb0120","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1016\/j.immuni.2021.05.003","article-title":"Uptake of oxidized lipids by the scavenger receptor CD36 promotes lipid peroxidation and dysfunction in CD8(+) T cells in tumors","volume":"54","author":"Xu","year":"2021","journal-title":"Immunity"},{"issue":"8","key":"10.1016\/j.ijbiomac.2026.152623_bb0125","doi-asserted-by":"crossref","DOI":"10.3390\/v14081814","article-title":"The function behind the relation between lipid metabolism and vimentin on H9N2 subtype AIV replication","volume":"14","author":"Lu","year":"2022","journal-title":"Viruses"},{"issue":"18","key":"10.1016\/j.ijbiomac.2026.152623_bb0130","doi-asserted-by":"crossref","first-page":"3033","DOI":"10.1007\/s00018-011-0735-1","article-title":"Vimentin in cancer and its potential as a molecular target for cancer therapy","volume":"68","author":"Satelli","year":"2011","journal-title":"Cell. Mol. Life Sci."},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.152623_bb0135","doi-asserted-by":"crossref","first-page":"97","DOI":"10.4093\/dmj.2019.0198","article-title":"Vimentin deficiency prevents high-fat diet-induced obesity and insulin resistance in mice","volume":"45","author":"Kim","year":"2021","journal-title":"Diabetes Metab. J."},{"key":"10.1016\/j.ijbiomac.2026.152623_bb0140","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.biochi.2022.02.003","article-title":"Vimentin: regulation and pathogenesis","volume":"197","author":"Paulin","year":"2022","journal-title":"Biochimie"},{"key":"10.1016\/j.ijbiomac.2026.152623_bb0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.ceb.2023.102265","article-title":"Extracellular vimentin: Battle between the devil and the angel","volume":"85","author":"Thalla","year":"2023","journal-title":"Curr. Opin. Cell Biol."},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.152623_bb0150","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.immuni.2018.12.021","article-title":"Intratumoral Tcf1(+)PD-1(+)CD8(+) T cells with stem-like properties promote tumor control in response to vaccination and checkpoint blockade immunotherapy","volume":"50","author":"Siddiqui","year":"2019","journal-title":"Immunity"},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.152623_bb0155","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1186\/s12935-021-02208-z","article-title":"USP7 inhibition induces apoptosis in glioblastoma by enhancing ubiquitination of ARF4","volume":"21","author":"Pan","year":"2021","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.ijbiomac.2026.152623_bb0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2020.107753","article-title":"Tumor microenvironment as a therapeutic target in cancer","volume":"221","author":"Xiao","year":"2021","journal-title":"Pharmacol. Ther."},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.152623_bb0165","doi-asserted-by":"crossref","DOI":"10.1172\/JCI163446","article-title":"Macrophages and microglia in glioblastoma: heterogeneity, plasticity, and therapy","volume":"133","author":"Khan","year":"2023","journal-title":"J. Clin. Invest."},{"issue":"8","key":"10.1016\/j.ijbiomac.2026.152623_bb0170","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1016\/j.tips.2022.04.002","article-title":"Pharmacological targeting of the tumor-immune symbiosis in glioblastoma","volume":"43","author":"Pang","year":"2022","journal-title":"Trends Pharmacol. Sci."},{"issue":"17","key":"10.1016\/j.ijbiomac.2026.152623_bb0175","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.134386","article-title":"Profiling of patients with glioma reveals the dominant immunosuppressive axis is refractory to immune function restoration","volume":"5","author":"Ott","year":"2020","journal-title":"JCI Insight"},{"issue":"10","key":"10.1016\/j.ijbiomac.2026.152623_bb0180","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1016\/j.immuni.2023.09.005","article-title":"CD8(+) T cells in the cancer-immunity cycle","volume":"56","author":"Giles","year":"2023","journal-title":"Immunity"},{"issue":"2","key":"10.1016\/j.ijbiomac.2026.152623_bb0185","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1038\/s41416-020-01048-4","article-title":"Cytotoxic CD8(+) T cells in cancer and cancer immunotherapy","volume":"124","author":"Raskov","year":"2021","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.ijbiomac.2026.152623_bb0190","article-title":"CD8(+) T cell exhaustion and its regulatory mechanisms in the tumor microenvironment: key to the success of immunotherapy","volume":"15","author":"Zhang","year":"2024","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.152623_bb0195","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1186\/s13046-022-02349-7","article-title":"Emerging therapies for glioblastoma: current state and future directions","volume":"41","author":"Rong","year":"2022","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"6","key":"10.1016\/j.ijbiomac.2026.152623_bb0200","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/s41568-019-0144-6","article-title":"Tertiary lymphoid structures in the era of cancer immunotherapy","volume":"19","author":"Sautes-Fridman","year":"2019","journal-title":"Nat. Rev. Cancer"},{"issue":"Pt 3","key":"10.1016\/j.ijbiomac.2026.152623_bb0205","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/j.semcancer.2021.12.006","article-title":"Vimentin and cytokeratin: good alone, bad together","volume":"86","author":"Kuburich","year":"2022","journal-title":"Semin. Cancer Biol."},{"issue":"6","key":"10.1016\/j.ijbiomac.2026.152623_bb0210","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbcan.2023.188985","article-title":"Extracellular vimentin as a versatile immune suppressive protein in cancer","volume":"1878","author":"van Loon","year":"2023","journal-title":"Biochim. Biophys. Acta Rev. Cancer"},{"issue":"3","key":"10.1016\/j.ijbiomac.2026.152623_bb0215","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1038\/s41577-019-0224-6","article-title":"TIM3 comes of age as an inhibitory receptor","volume":"20","author":"Wolf","year":"2020","journal-title":"Nat. Rev. Immunol."},{"issue":"10","key":"10.1016\/j.ijbiomac.2026.152623_bb0220","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1084\/jem.20100643","article-title":"Targeting Tim-3 and PD-1 pathways to reverse T cell exhaustion and restore anti-tumor immunity","volume":"207","author":"Sakuishi","year":"2010","journal-title":"J. Exp. Med."},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.152623_bb0225","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1038\/s41467-021-21099-2","article-title":"Galectin-9 interacts with PD-1 and TIM-3 to regulate T cell death and is a target for cancer immunotherapy","volume":"12","author":"Yang","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ijbiomac.2026.152623_bb0230","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/bs.mie.2019.05.020","article-title":"CFSE dilution to study human T and NK cell proliferation in vitro","volume":"631","author":"Terren","year":"2020","journal-title":"Methods Enzymol."},{"key":"10.1016\/j.ijbiomac.2026.152623_bb0235","article-title":"Analysis of human T cell activity in an allogeneic co-culture setting of pre-treated tumor cells","volume":"217","author":"Donaubauer","year":"2025","journal-title":"J. Vis. Exp."},{"issue":"3","key":"10.1016\/j.ijbiomac.2026.152623_bb0240","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.3892\/mmr.2014.2914","article-title":"Ki67 is a promising molecular target in the diagnosis of cancer (review)","volume":"11","author":"Li","year":"2015","journal-title":"Mol. Med. Rep."},{"issue":"7\u20138","key":"10.1016\/j.ijbiomac.2026.152623_bb0245","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1101\/gad.349358.122","article-title":"Roles of vimentin in health and disease","volume":"36","author":"Ridge","year":"2022","journal-title":"Genes Dev."},{"issue":"4","key":"10.1016\/j.ijbiomac.2026.152623_bb0250","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1111\/wrr.12920","article-title":"Vimentin regulates the assembly and function of matrix adhesions","volume":"29","author":"Ostrowska-Podhorodecka","year":"2021","journal-title":"Wound Repair Regen."},{"issue":"587","key":"10.1016\/j.ijbiomac.2026.152623_bb0255","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaz6314","article-title":"Reprogramming lipid metabolism prevents effector T cell senescence and enhances tumor immunotherapy","volume":"13","author":"Liu","year":"2021","journal-title":"Sci. Transl. Med."},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.152623_bb0260","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1038\/s41467-017-00910-z","article-title":"The cholesterol metabolite 27 hydroxycholesterol facilitates breast cancer metastasis through its actions on immune cells","volume":"8","author":"Baek","year":"2017","journal-title":"Nat. Commun."},{"issue":"7","key":"10.1016\/j.ijbiomac.2026.152623_bb0265","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2024-008811","article-title":"Harnessing lipid metabolism modulation for improved immunotherapy outcomes in lung adenocarcinoma","volume":"12","author":"Chen","year":"2024","journal-title":"J. Immunother. Cancer"},{"issue":"3","key":"10.1016\/j.ijbiomac.2026.152623_bb0270","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.immuni.2015.08.023","article-title":"The cellular and molecular basis of translational Immunometabolism","volume":"43","author":"Norata","year":"2015","journal-title":"Immunity"},{"issue":"7","key":"10.1016\/j.ijbiomac.2026.152623_bb0275","first-page":"1045","article-title":"Tumor-associated macrophages restrict CD8(+) T cell function through collagen deposition and metabolic reprogramming of the breast cancer microenvironment","volume":"5","author":"Tharp","year":"2024","journal-title":"Nat. Can."},{"issue":"8","key":"10.1016\/j.ijbiomac.2026.152623_bb0280","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1038\/nm.2172","article-title":"Lipid accumulation and dendritic cell dysfunction in cancer","volume":"16","author":"Herber","year":"2010","journal-title":"Nat. Med."},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.152623_bb0285","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/s42255-020-00317-z","article-title":"Metabolites and the tumour microenvironment: from cellular mechanisms to systemic metabolism","volume":"3","author":"Elia","year":"2021","journal-title":"Nat. Metab."},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.152623_bb0290","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1186\/s13045-021-01200-4","article-title":"Contradictory roles of lipid metabolism in immune response within the tumor microenvironment","volume":"14","author":"Yu","year":"2021","journal-title":"J. Hematol. Oncol."},{"issue":"12","key":"10.1016\/j.ijbiomac.2026.152623_bb0295","doi-asserted-by":"crossref","DOI":"10.3390\/metabo12121280","article-title":"Lipid alterations in glioma: a systematic review","volume":"12","author":"Abdul Rashid","year":"2022","journal-title":"Metabolites"},{"issue":"4","key":"10.1016\/j.ijbiomac.2026.152623_bb0300","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s44307-024-00040-w","article-title":"Regulation of autophagy by protein lipidation","volume":"2","author":"Shao","year":"2024","journal-title":"Adv Biotechnol (Singap)"},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.152623_bb0305","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1080\/15548627.2021.2021495","article-title":"The exploitation of host autophagy and ubiquitin machinery by mycobacterium tuberculosis in shaping immune responses and host defense during infection","volume":"19","author":"Shariq","year":"2023","journal-title":"Autophagy"},{"key":"10.1016\/j.ijbiomac.2026.152623_bb0310","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1146\/annurev-biochem-061516-044916","article-title":"Mechanisms of Deubiquitinase specificity and regulation","volume":"86","author":"Mevissen","year":"2017","journal-title":"Annu. Rev. Biochem."},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.152623_bb0315","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/s41419-023-05552-2","article-title":"FRMD3 inhibits the growth and metastasis of breast cancer through the ubiquitination-mediated degradation of vimentin and subsequent impairment of focal adhesion","volume":"14","author":"Shao","year":"2023","journal-title":"Cell Death Dis."},{"issue":"4","key":"10.1016\/j.ijbiomac.2026.152623_bb0320","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24043219","article-title":"Ubiquitin-specific proteases (USPs) and metabolic disorders","volume":"24","author":"Kitamura","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"6","key":"10.1016\/j.ijbiomac.2026.152623_bb0325","doi-asserted-by":"crossref","first-page":"2267","DOI":"10.14336\/AD.2023.0325-1","article-title":"USP7 inhibits Osteoclastogenesis via dual effects of attenuating TRAF6\/TAK1 axis and stimulating STING signaling","volume":"14","author":"Xie","year":"2023","journal-title":"Aging Dis."},{"issue":"6","key":"10.1016\/j.ijbiomac.2026.152623_bb0330","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbcan.2023.188992","article-title":"Current and future directions of USP7 interactome in cancer study","volume":"1878","author":"Park","year":"2023","journal-title":"Biochim. Biophys. Acta Rev. Cancer"},{"key":"10.1016\/j.ijbiomac.2026.152623_bb0335","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/978-981-15-3266-5_3","article-title":"Roles of PD-1\/PD-L1 pathway: signaling, Cancer, and beyond","volume":"1248","author":"Ai","year":"2020","journal-title":"Adv. Exp. Med. Biol."},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.152623_bb0340","article-title":"Anti-PD-1 and anti-PD-L1 antibodies for glioma","volume":"1","author":"de Melo","year":"2025","journal-title":"Cochrane Database Syst. Rev."},{"issue":"9","key":"10.1016\/j.ijbiomac.2026.152623_bb0345","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1016\/j.cmet.2022.08.002","article-title":"Aerobic glycolysis promotes tumor immune evasion by hexokinase2-mediated phosphorylation of IkappaBalpha","volume":"34","author":"Guo","year":"2022","journal-title":"Cell Metab."},{"issue":"4","key":"10.1016\/j.ijbiomac.2026.152623_bb0350","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.ccell.2023.03.004","article-title":"Neutralizing IL-8 potentiates immune checkpoint blockade efficacy for glioma","volume":"41","author":"Liu","year":"2023","journal-title":"Cancer Cell"},{"issue":"18","key":"10.1016\/j.ijbiomac.2026.152623_bb0355","article-title":"Metabolism\/immunity dual-regulation thermogels potentiating immunotherapy of glioblastoma through lactate-excretion inhibition and PD-1\/PD-L1 blockade","volume":"11","author":"Li","year":"2024","journal-title":"Adv Sci (Weinh)"}],"container-title":["International Journal of Biological Macromolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S014181302602550X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S014181302602550X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T13:24:18Z","timestamp":1783171458000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S014181302602550X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":71,"alternative-id":["S014181302602550X"],"URL":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2026.152623","relation":{},"ISSN":["0141-8130"],"issn-type":[{"value":"0141-8130","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The USP7\u2013VIM axis mediates lipid metabolic remodelling and compromises CD8+ T-cell mitochondrial fitness in glioblastoma","name":"articletitle","label":"Article Title"},{"value":"International Journal of Biological Macromolecules","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2026.152623","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"152623"}}